鼎捷軟件(300378.SZ):目前與華為的合作主要集中於IaaS服務層面
格隆匯7月17日丨有投資者向鼎捷軟件(300378.SZ)提問,“2023年7月6-8日上海舉辦世界人工智能大會,請問董祕貴公司有參加本屆AI大會嗎?7月7日華為開發者Cloud大會召開,請問董祕貴公司和華為雲和人工智能方面有哪些實質性合作?”
鼎捷軟件回覆稱,公司未參加相關活動;公司是華為戰略合作伙伴,於2019年成為華為精英服務商以及鯤鵬凌雲夥伴、公司多款產品通過華為鯤鵬認證,並先後獲得華為嚴選合作伙伴等榮譽,目前公司與華為的合作主要集中於IaaS服務層面,後續公司若有任何進一步合作進展,公司會合法合規及時披露,敬請關注後續公吿或關注公司官網、公眾號等最新消息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.